{"id":"https://openalex.org/W1968484876","doi":"https://doi.org/10.1002/phar.1575","title":"Overview of Current and Alternative Therapies for Idiopathic Membranous Nephropathy","display_name":"Overview of Current and Alternative Therapies for Idiopathic Membranous Nephropathy","publication_year":2015,"publication_date":"2015-04-01","ids":{"openalex":"https://openalex.org/W1968484876","doi":"https://doi.org/10.1002/phar.1575","mag":"1968484876","pmid":"https://pubmed.ncbi.nlm.nih.gov/25884528"},"language":"en","primary_location":{"id":"doi:10.1002/phar.1575","doi":"https://doi.org/10.1002/phar.1575","is_oa":false,"landing_page_url":"https://doi.org/10.1002/phar.1575","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101795560","display_name":"Tran H. Tran","orcid":"https://orcid.org/0000-0002-0537-7566","observed_orcids":["https://orcid.org/0000-0002-0537-7566"]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I142823887","display_name":"St. John's University","ror":"https://ror.org/00bgtad15","country_code":"US","type":"education","lineage":["https://openalex.org/I142823887"]},{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Tran H. Tran","raw_affiliation_strings":["College of Pharmacy and Health Sciences; St. John's University; Queens New York","NewYork\u2010Presbyterian Hospital/Columbia University Medical Center New York New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Pharmacy and Health Sciences; St. John's University; Queens New York","institution_ids":["https://openalex.org/I142823887"]},{"raw_affiliation_string":"NewYork\u2010Presbyterian Hospital/Columbia University Medical Center New York New York","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103155710","display_name":"Gregory J Hughes","orcid":"https://orcid.org/0000-0003-2333-5797","observed_orcids":["https://orcid.org/0000-0003-2333-5797","https://orcid.org/0009-0009-7470-9569"]},"institutions":[{"id":"https://openalex.org/I142823887","display_name":"St. John's University","ror":"https://ror.org/00bgtad15","country_code":"US","type":"education","lineage":["https://openalex.org/I142823887"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory J. Hughes","raw_affiliation_strings":["College of Pharmacy and Health Sciences St. John's University Queens New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Pharmacy and Health Sciences St. John's University Queens New York","institution_ids":["https://openalex.org/I142823887"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033063162","display_name":"Chuck R Greenfeld","orcid":"https://orcid.org/0000-0002-4230-178X","observed_orcids":["https://orcid.org/0000-0002-4230-178X"]},"institutions":[{"id":"https://openalex.org/I4210102181","display_name":"Mallinckrodt (United States)","ror":"https://ror.org/01akman82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210102181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chuck Greenfeld","raw_affiliation_strings":["Mallinckrodt Pharmaceuticals St. Louis Missouri"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mallinckrodt Pharmaceuticals St. Louis Missouri","institution_ids":["https://openalex.org/I4210102181"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060740497","display_name":"Jacqueline T. Pham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102181","display_name":"Mallinckrodt (United States)","ror":"https://ror.org/01akman82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210102181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacqueline T. Pham","raw_affiliation_strings":["Mallinckrodt Pharmaceuticals St. Louis Missouri"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mallinckrodt Pharmaceuticals St. Louis Missouri","institution_ids":["https://openalex.org/I4210102181"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5101795560"],"corresponding_institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I142823887","https://openalex.org/I2799503643"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":0.5531,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.45024631,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"35","issue":"4","first_page":"396","last_page":"411"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idiopathic-membranous-nephropathy","display_name":"idiopathic membranous nephropathy","score":1.0},{"id":"https://openalex.org/keywords/nephrotic-syndrome","display_name":"nephrotic syndrome","score":0.9810000061988831},{"id":"https://openalex.org/keywords/immunosuppressive-therapy","display_name":"immunosuppressive therapy","score":0.9829999804496765},{"id":"https://openalex.org/keywords/calcineurin-inhibitors","display_name":"calcineurin inhibitors","score":0.9089999794960022},{"id":"https://openalex.org/keywords/alkylating-agents","display_name":"alkylating agents","score":0.9070000052452087},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.8560000061988831},{"id":"https://openalex.org/keywords/mycophenolate-mofetil","display_name":"mycophenolate mofetil","score":0.9990000128746033},{"id":"https://openalex.org/keywords/acth","display_name":"ACTH","score":0.9829999804496765},{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":1.0},{"id":"https://openalex.org/keywords/azathioprine","display_name":"azathioprine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/disease-progression-risk","display_name":"disease progression risk","score":0.5809999704360962},{"id":"https://openalex.org/keywords/treatment-selection","display_name":"treatment selection","score":0.4620000123977661}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9426106810569763},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6246820092201233},{"id":"https://openalex.org/C2775946357","wikidata":"https://www.wikidata.org/wiki/Q1713037","display_name":"Membranous nephropathy","level":4,"score":0.529898464679718},{"id":"https://openalex.org/C2778930706","wikidata":"https://www.wikidata.org/wiki/Q504790","display_name":"Nephrotic syndrome","level":2,"score":0.5110548734664917},{"id":"https://openalex.org/C2776760755","wikidata":"https://www.wikidata.org/wiki/Q18939","display_name":"Azathioprine","level":3,"score":0.5032104849815369},{"id":"https://openalex.org/C2776009029","wikidata":"https://www.wikidata.org/wiki/Q1640780","display_name":"Hypoalbuminemia","level":2,"score":0.4279007017612457},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41808706521987915},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.4142940640449524},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.4085509777069092},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.34146347641944885},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.19465231895446777},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.14470329880714417},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.10874122381210327}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015433","descriptor_name":"Glomerulonephritis, Membranous","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015433","descriptor_name":"Glomerulonephritis, Membranous","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/phar.1575","doi":"https://doi.org/10.1002/phar.1575","is_oa":false,"landing_page_url":"https://doi.org/10.1002/phar.1575","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},{"id":"pmid:25884528","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25884528","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320315076","display_name":"Mallinckrodt Pharmaceuticals","ror":null},{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W76687339","https://openalex.org/W1701911634","https://openalex.org/W1979815666","https://openalex.org/W1982975210","https://openalex.org/W1985789388","https://openalex.org/W2005648142","https://openalex.org/W2005989846","https://openalex.org/W2008615274","https://openalex.org/W2010214780","https://openalex.org/W2011665041","https://openalex.org/W2018459774","https://openalex.org/W2027077465","https://openalex.org/W2030924703","https://openalex.org/W2039760414","https://openalex.org/W2050449333","https://openalex.org/W2076054383","https://openalex.org/W2089157915","https://openalex.org/W2089916413","https://openalex.org/W2090021700","https://openalex.org/W2095787590","https://openalex.org/W2101558297","https://openalex.org/W2104602296","https://openalex.org/W2107002794","https://openalex.org/W2108432978","https://openalex.org/W2111285312","https://openalex.org/W2111892488","https://openalex.org/W2115472834","https://openalex.org/W2116986363","https://openalex.org/W2118253697","https://openalex.org/W2122581834","https://openalex.org/W2125226221","https://openalex.org/W2127974063","https://openalex.org/W2131815197","https://openalex.org/W2137807773","https://openalex.org/W2141219630","https://openalex.org/W2142377667","https://openalex.org/W2144479843","https://openalex.org/W2147397632","https://openalex.org/W2150460695","https://openalex.org/W2153604508","https://openalex.org/W2157296439","https://openalex.org/W2160726185","https://openalex.org/W2166822765","https://openalex.org/W2256878291","https://openalex.org/W2259519325","https://openalex.org/W2317894951","https://openalex.org/W2322148317","https://openalex.org/W2326202408","https://openalex.org/W2409577554","https://openalex.org/W2412239597","https://openalex.org/W2594454279","https://openalex.org/W3094568071"],"related_works":["https://openalex.org/W2113836568","https://openalex.org/W1994288081","https://openalex.org/W2012909018","https://openalex.org/W2091693558","https://openalex.org/W2115928661","https://openalex.org/W1963948820","https://openalex.org/W1567661960","https://openalex.org/W2002664599","https://openalex.org/W2184616726","https://openalex.org/W2386217412"],"abstract_inverted_index":{"Membranous":[0],"nephropathy":[1,27],"is":[2,14,32,57,100,107,199,238],"one":[3],"of":[4,8,24,54,80,92,111,183,194,239,277,297],"the":[5,90,192,206,236,275,293],"leading":[6],"causes":[7],"nephrotic":[9],"syndrome":[10],"in":[11,51,104,197,272],"adults,":[12],"which":[13,62],"characterized":[15],"by":[16],"edema,":[17],"hypoalbuminemia,":[18],"hyperlipidemia,":[19],"lipiduria,":[20],"and":[21,114,217,242,264,280,295],"proteinuria.":[22],"Determination":[23],"idiopathic":[25],"membranous":[26],"(IMN)":[28],"disease":[29,283],"progression":[30],"risk":[31],"important":[33,58],"for":[34,43,126,139,149,191,209,232,259],"guiding":[35],"initial":[36,159],"therapy,":[37],"with":[38,85,132,151,174,177,187,225,286],"immunosuppressive":[39,66],"therapy":[40,67,137,258],"being":[41],"reserved":[42],"high-risk":[44,105,127],"patients.":[45,261],"Because":[46],"IMN":[47,106,152,198,298],"may":[48],"spontaneously":[49],"remit":[50],"approximately":[52],"30%":[53],"patients,":[55],"it":[56],"to":[59,70,155,158,168,268,301],"carefully":[60],"select":[61],"patients":[63,128,150],"should":[64],"begin":[65],"so":[68],"as":[69,257],"maximize":[71],"clinical":[72],"benefit":[73],"while":[74],"limiting":[75],"toxicity.":[76,227],"An":[77],"observation":[78],"period":[79],"at":[81,201],"least":[82],"6":[83],"months":[84],"conservative":[86],"management":[87,294],"that":[88],"includes":[89],"use":[91,164,193],"angiotensin-converting":[93],"enzyme":[94],"inhibitors":[95,118],"or":[96,134,138,161,170,180],"angiotensin":[97],"receptor":[98],"blockers":[99],"recommended.":[101],"Initial":[102],"treatment":[103,131,291],"a":[108,230,270],"6-month":[109],"course":[110],"alternating":[112],"steroids":[113],"alkylating":[115,135,178],"agents.":[116],"Calcineurin":[117],"(CNIs)":[119],"represent":[120],"an":[121],"alternative":[122,195],"first-line":[123],"therapeutic":[124],"option":[125],"who":[129,153,162],"refuse":[130],"steroid":[133],"agent":[136],"whom":[140],"these":[141],"treatments":[142],"are":[143,147,249,266,299],"contraindicated.":[144],"Additional":[145],"options":[146],"essential":[148],"fail":[154],"adequately":[156],"respond":[157],"therapies":[160,166,196],"cannot":[163],"recommended":[165,256],"due":[167],"contraindications":[169],"intolerance,":[171],"risks":[172],"associated":[173],"repetitive":[175],"dosing":[176],"agents,":[179],"potential":[181],"exacerbation":[182],"impaired":[184],"renal":[185],"function":[186],"CNIs.":[188],"While":[189],"evidence":[190,237],"modest":[200],"best,":[202],"our":[203],"review":[204],"summarizes":[205],"available":[207],"literature":[208],"rituximab,":[210],"mycophenolate":[211,233],"mofetil,":[212,234],"adrenocorticotropic":[213,252],"hormone,":[214],"intravenous":[215],"immunoglobulin,":[216],"azathioprine.":[218],"Rituximab":[219],"has":[220],"generally":[221],"demonstrated":[222],"beneficial":[223],"outcomes":[224],"limited":[226,243],"Evidence":[228],"supports":[229],"role":[231,271],"although":[235],"low":[240],"quality":[241],"duration.":[244],"Results":[245],"from":[246],"ongoing":[247],"studies":[248],"required":[250],"before":[251],"hormone":[253],"can":[254],"be":[255],"treatment-resistant":[260],"Intravenous":[262],"immunoglobulin":[263],"azathioprine":[265],"unlikely":[267],"have":[269],"IMN.":[273],"With":[274],"advent":[276],"new":[278,287],"tools":[279],"biomarkers":[281],"measuring":[282],"activity":[284],"combined":[285],"data":[288],"regarding":[289],"possible":[290],"options,":[292],"prognosis":[296],"likely":[300],"improve.":[302]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}